Belviq and Belviq XR - Creates an Increase Risk of Cancer

Belviq (generic name: lorcaserin) is a popular prescription weight-loss drug made by Eisai Inc. to help people experiencing obesity and weight-related health issues curb their hunger. Alarmingly, a U.S. Food and Drug Administration (FDA) safety trial concluded that the drug could increase the risk of several different types of cancer, including pancreatic, lung, and colorectal cancer. As a result, the FDA issued a full recall of Belviq in February 2020. If you were diagnosed with cancer after taking Belviq, fill out a contact form and send us a message to see if one of the law firms in the law center network can help you. Use the link here: https://thelawcenter.net/contact-us-2/ https://thelawcenter.net/accidents/ Sponsored by the law firm of DeMarco & DeMarco, P.C., serving generations of clients for generations. To learn more go to: https://demarcoanddemarco.com #TheLawCenter #triallawyer #personalinjury #personalinjurylawyer